Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Casma Therapeutics (United States) | Researchclopedia

Back to institutions

Casma Therapeutics (United States)

Cambridge, Massachusettscompany

40

Works

3,499

Citations

32

h-index

Top Research Topics

Autophagy in Disease and Therapy Cellular transport and secretion Calcium signaling and nucleotide metabolism

Top Researchers

Andrea Ballabio

583 works75,013 citationsh-index: 120

Recent Research

TRPML1 suppresses pulmonary fibrosis by limiting collagen and elastin deposition

Eva-Maria Weiden,Zala Serianz,et al.

20260 citations

DNA Repair Mechanisms

Mosquito-borne diseases and control

Lipid Membrane Structure and Behavior

Microtubule and mitosis dynamics

Lysosomal Storage Disorders Research

HIV Research and Treatment

Fungal and yeast genetics research

HER2/EGFR in Cancer Research

CRISPR and Genetic Engineering

James E. Haber Brandeis University

536 works65,827 citationsh-index: 124

Carlos Bustamante QB3

565 works52,028 citationsh-index: 113

James H. Hurley

414 works36,796 citationsh-index: 93

Peter S. Hammerman Casma Therapeutics (United States)

668 works30,914 citationsh-index: 71

Hans‐Peter Gerber Sutro Biopharma (United States)

240 works27,840 citationsh-index: 58

HMB-002: A Monovalent Antibody that Elevates Circulating VWF and FVIII Levels for Treatment of Von Willebrand Disease

Mattias Häger,Minka Živkovic,et al.

20260 citations

A Dose-Selection Study of Clobetasol Propionate Ophthalmic Suspension that Evaluated Inflammation and Pain after Cataract Surgery

Jeffrey Levenson,Thomas R. Walters,et al.

20250 citations

A single dose of a CD137 antibody–drug conjugate protects rhesus macaque allogeneic HCT recipients against acute GVHD

Ulrike Gerdemann,Kyle Kimler,et al.

20251 citations

Abstract 4205: Direct measurement of TA repeat expansions significantly outperforms MSI-H status as a predictor of sensitivity to the novel WRN inhibitor MOMA-341

Anthony Tubbs,Javad Golji,et al.

20252 citations

Abstract 1749: Discovery of MOMA-313, a potent and selective inhibitor of the Polθ DNA helicase domain for the treatment of HR-deficient tumors

Jordan A. Krall,Michael H. Reutershan,et al.

20250 citations